Literature DB >> 34204735

Hyperactivated RAGE in Comorbidities as a Risk Factor for Severe COVID-19-The Role of RAGE-RAS Crosstalk.

Sara Chiappalupi1,2, Laura Salvadori2,3, Rosario Donato2, Francesca Riuzzi1,2,4, Guglielmo Sorci1,2,4,5.   

Abstract

The receptor for advanced glycation-end products (RAGE) is a multiligand receptor with a role in inflammatory and pulmonary pathologies. Hyperactivation of RAGE by its ligands has been reported to sustain inflammation and oxidative stress in common comorbidities of severe COVID-19. RAGE is essential to the deleterious effects of the renin-angiotensin system (RAS), which participates in infection and multiorgan injury in COVID-19 patients. Thus, RAGE might be a major player in severe COVID-19, and appears to be a useful therapeutic molecular target in infections by SARS-CoV-2. The role of RAGE gene polymorphisms in predisposing patients to severe COVID-19 is discussed.&nbsp.

Entities:  

Keywords:  AGER polymorphisms; COVID-19 comorbidities; RAGE

Year:  2021        PMID: 34204735     DOI: 10.3390/biom11060876

Source DB:  PubMed          Journal:  Biomolecules        ISSN: 2218-273X


  6 in total

Review 1.  RAGE against the Machine: Can Increasing Our Understanding of RAGE Help Us to Battle SARS-CoV-2 Infection in Pregnancy?

Authors:  Courtney K Kurashima; Po'okela K Ng; Claire E Kendal-Wright
Journal:  Int J Mol Sci       Date:  2022-06-07       Impact factor: 6.208

2.  Soluble RAGE as a Prognostic Marker of Worsening in Patients Admitted to the ICU for COVID-19 Pneumonia: A Prospective Cohort Study.

Authors:  Emmanuel Besnier; Valéry Brunel; Caroline Thill; Perrine Leprêtre; Jérémy Bellien; Zoe Demailly; Sylvanie Renet; Fabienne Tamion; Thomas Clavier
Journal:  J Clin Med       Date:  2022-08-05       Impact factor: 4.964

Review 3.  Receptor for Advanced Glycation End Products (RAGE): A Pivotal Hub in Immune Diseases.

Authors:  Qing Yue; Yu Song; Zi Liu; Lin Zhang; Ling Yang; Jinlong Li
Journal:  Molecules       Date:  2022-08-02       Impact factor: 4.927

4.  Reply to Jain: High Circulating Plasma Soluble Receptor for Advanced Glycation End-Products in Early COVID-19-associated Acute Respiratory Distress Syndrome: Pathophysiological Significance?

Authors:  Guillaume Dumas; Natacha Kapandji; Elie Azoulay; Jean-Michel Constantin
Journal:  Am J Respir Crit Care Med       Date:  2022-01-15       Impact factor: 21.405

5.  Integrative Role of Albumin: Evolutionary, Biochemical and Pathophysiological Aspects.

Authors:  D A Belinskaia; P A Voronina; N V Goncharov
Journal:  J Evol Biochem Physiol       Date:  2021-12-20       Impact factor: 0.444

6.  High Circulating Plasma Soluble Receptor for Advanced Glycation End-Products in Early COVID-19-associated Acute Respiratory Distress Syndrome: Pathophysiological Significance?

Authors:  Amit Jain
Journal:  Am J Respir Crit Care Med       Date:  2022-01-15       Impact factor: 21.405

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.